Novo Nordisks øverste kommercielle chef, Camilla Sylvest, stoppede torsdag, mens topchef Lars Fruergaard Jørgensen benyttede lejligheden til at rykke rundt på brikkerne i topledelsen. Det sker for at ...

Novo Nordisk said the Food ... GLP-1 drug on the market, the Bagsvaerd, Denmark, company said. The FDA approved semaglutide for weight loss under the brand name Wegovy in 2021.

WASHINGTON-The Trump administration has embarked on a high-speed effort to negotiate ad hoc deals with more than 70 countries hoping to escape higher tariffs, with any agreements likely to fall short ...

In clinical trials, one of the leading types of such treatments, semaglutide (also known by the brand names Ozempic ... managed weight loss of over 20%. Novo Nordisk is not the only company ...

Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity is now under attack on multiple fronts, from ...

Danish drugmaker Novo Nordisk said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being ...

Bagsværd, Denmark-based Novo Nordisk is a global healthcare company and a prominent player in the diabetes market with a full portfolio of glucagon-like peptide 1 (GLP-1) receptor agonists ...

April 14 (Reuters) - Danish drugmaker Novo Nordisk NOVOb.CO said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized supply chain ...

Under the license agreement, Novo Nordisk will obtain exclusive worldwide rights (excluding Chinese mainland, Hong Kong, Macau, and Taiwan) to develop, manufacture, and commercialize UBT251 ...

Guangdong, China and Bagsværd, Denmark, 24 March 2025 –The United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S (Novo Nordisk) today announced that Novo Nordisk and TUL’s ...

The popularity of Novo Nordisk's Ozempic and Wegovy has attracted competitors and created supply constraints. Novo Nordisk's next-generation weight loss drug disappointed investors in Phase III ...